Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Comparing how exercise affects blood sugar in adults with and without Type 1 diabetes.

Official title: Inter- and Intraindividual Variability of the Acute Glucose Response to Exercise in Healthy Adults and People Living With Type 1 Diabetes: A Cross-over Replicate Trial

Run by University College Dublin · NCT07209930 · Data updated 2026-11-12

We will see if a standardized bout of cycling causes similar blood sugar changes within the same person and between people, in adults with Type 1 diabetes and in healthy adults, using continuous glucose monitors and finger‑stick checks.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment24 (estimated)
SponsorUniversity College Dublin
Academic / other
Locations1 site (Dublin, Dublin)
StatusRecruiting
StartedJanuary 28, 2025
Main results expectedDecember 31, 2025
Study endsJuly 31, 2026
Registry record updatedOctober 7, 2025
Trial IDNCT07209930 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–60 who either have Type 1 diabetes for more than 18 months with intact hypoglycaemia self‑awareness and ability to self‑manage their diabetes, or are healthy adults without diabetes who engage in physical activity at least once weekly, are suitable candidates.

Probably not a fit

People with cardiovascular disease or other contraindications to exercise, pregnancy, chronic renal or liver disease, diagnosed eating disorders, active infection, or those unable to safely self‑manage diabetes (including loss of hypoglycaemia awareness) are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized replicate crossover trial with two parallel phases: one for adults with Type 1 diabetes and one for healthy adults, each recruiting about 12 participants. After baseline testing (including body composition and VO2max), participants complete two test conditions (exercise on a cycle ergometer and rest) in randomized order and then repeat the same order the following week to measure reproducibility. Glucose is tracked continuously by CGM and intermittently by capillary blood sampling after a standardized breakfast, with at least 72 hours between test visits. The design compares within‑person repeatability and between‑person variability and also evaluates agreement between CGM and finger‑stick glucose values.

Why it matters

Potential benefit: If successful, the results could help predict individual glucose responses to exercise and improve personalized guidance for safe physical activity in people with Type 1 diabetes.

How similar studies have gone: Prior research has documented substantial variability in glucose responses to exercise and mixed agreement between CGM and capillary blood, so this work builds on existing but unresolved evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

(Healthy and T1D phases):

* age between 18 and 60 years old;
* being healthy individuals;
* engagement in physical activity at least once a week; (T1D phase):
* diagnosis of T1D for \>18 months;
* hypoglycaemia self awareness.

Exclusion Criteria:

(Healthy and T1D phases)

* presence of cardiovascular disease or contraindications to exercise;
* infectious or inflammatory conditions;
* chronic renal or liver disease;
* pregnancy;
* gestational diabetes;
* diagnosed eating disorders;
* any physical or mental condition preventing participation; (Healthy phase)
* diabetes mellitus (type 1 or type 2); (T1D phase)
* inability to self-manage diabetes.

Where it's running

  • University College Dublin
    Dublin, Dublin, Ireland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.